27-12-2024 18:08
via
news.google.com
Galectin Therapeutics (NASDAQ:GALT) Earns Neutral Rating from HC Wainwright - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Earns Neutral Rating from HC Wainwright MarketBeat
Read more »